133 related articles for article (PubMed ID: 21435910)
1. Reversible dementia and gait disturbance after prolonged use of valproic acid.
Evans MD; Shinar R; Yaari R
Seizure; 2011 Jul; 20(6):509-11. PubMed ID: 21435910
[TBL] [Abstract][Full Text] [Related]
2. [Dementia and extrapyramidal problems caused by long-term valproic acid].
Masmoudi K; Gras-Champel V; Bonnet I; Pannier M; Masson H; Rosa A; Andréjak M
Therapie; 2000; 55(5):629-34. PubMed ID: 11201978
[TBL] [Abstract][Full Text] [Related]
3. [Reversible dementia due to valproic acid therapy].
Walstra GJ
Ned Tijdschr Geneeskd; 1997 Feb; 141(8):391-3. PubMed ID: 9157301
[TBL] [Abstract][Full Text] [Related]
4. Parkinsonism and/or cognitive impairment with valproic acid therapy: a report of ten cases.
Masmoudi K; Gras-Champel V; Masson H; Andréjak M
Pharmacopsychiatry; 2006 Jan; 39(1):9-12. PubMed ID: 16453247
[TBL] [Abstract][Full Text] [Related]
5. [Reversible dementia-like condition and parkinsonism in an elderly woman. Idiosyncratic adverse effects connected to 11 years of antiepileptic medication].
Lindbom U; Taubert B; Fahlqvist MS; Bergens A; Kimland E; Jonsson EW; Bergman U
Lakartidningen; 2009 Mar 18-24; 106(12):863-5. PubMed ID: 19452788
[No Abstract] [Full Text] [Related]
6. [Valproate can induce reversible encephalopathy].
Prakash S; Harbo T; Christensen J
Ugeskr Laeger; 2015 May; 177(20):945-6. PubMed ID: 26535436
[TBL] [Abstract][Full Text] [Related]
7. Gait instability in valproate-treated patients: Call to measure ammonia levels.
Kipervasser S; Elger CE; Korczyn AD; Nass RD; Quesada CM; Neufeld MY
Acta Neurol Scand; 2017 Nov; 136(5):401-406. PubMed ID: 28436001
[TBL] [Abstract][Full Text] [Related]
8. Levetiracetam compared to valproic acid: plasma concentration levels, adverse effects and interactions in aneurysmal subarachnoid hemorrhage.
Mink S; Muroi C; Seule M; Bjeljac M; Keller E
Clin Neurol Neurosurg; 2011 Oct; 113(8):644-8. PubMed ID: 21703756
[TBL] [Abstract][Full Text] [Related]
9. [Valproate can induce reversible encephalopathy].
Prakash S; Harbo T; Christensen J
Ugeskr Laeger; 2014 Nov; 176(45):. PubMed ID: 25394838
[TBL] [Abstract][Full Text] [Related]
10. Effect of valproic acid on dementia onset in patients with bipolar disorder.
Tsai PS; Liu IC; Chiu CH; Huang CJ; Wang MY
J Affect Disord; 2016 Sep; 201():131-6. PubMed ID: 27208500
[TBL] [Abstract][Full Text] [Related]
11. Urine Incontinence Induced by Valproic Acid.
Sudan YS; Bansal AR
Indian J Pediatr; 2017 Nov; 84(11):867-868. PubMed ID: 28577199
[No Abstract] [Full Text] [Related]
12. Reversible cognitive and neurological symptoms during valproic acid therapy.
Hommet C; Mondon K; de Toffol B; Constans T
J Am Geriatr Soc; 2007 Apr; 55(4):628. PubMed ID: 17397449
[No Abstract] [Full Text] [Related]
13. Serum biotinidase activity in children treated with valproic acid and carbamazepine.
Castro-Gago M; Gómez-Lado C; Eirís-Puñal J; Díaz-Mayo I; Castiñeiras-Ramos DE
J Child Neurol; 2010 Jan; 25(1):32-5. PubMed ID: 19458381
[TBL] [Abstract][Full Text] [Related]
14. [Acute Intermittent porphyria and valproic acid].
Noval Menéndez J; Campoamor MT; Laborda B; López-Colina G
Rev Clin Esp; 2012 Apr; 212(4):217-8. PubMed ID: 22112281
[No Abstract] [Full Text] [Related]
15. The effect of valproic acid on blood loss in patients with cerebral palsy.
Chambers HG; Weinstein CH; Mubarak SJ; Wenger DR; Silva PD
J Pediatr Orthop; 1999; 19(6):792-5. PubMed ID: 10573351
[TBL] [Abstract][Full Text] [Related]
16. [Dementia syndrome in an elderly subject related to valproic acid use: a case report].
Manckoundia P; Disson-Dautriche A; Rouaud O; Richard D; Tavernier-Vidal B; Pfitzenmeyer P
Rev Med Interne; 2008 Oct; 29(10):827-9. PubMed ID: 18572280
[TBL] [Abstract][Full Text] [Related]
17. Reversible rapidly progressive dementia with parkinsonism induced by valproate in a patient with systemic lupus erythematosus.
Sleegers MJ; Beutler JJ; Hardon WJ; Berden JH; Verhave JC; Conemans JM; Hollander DA; Dautzenberg PL; Hoogeveen EK
J Am Geriatr Soc; 2010 Apr; 58(4):799-801. PubMed ID: 20398172
[No Abstract] [Full Text] [Related]
18. When to consider normal pressure hydrocephalus in the patient with gait disturbance.
Factora R; Luciano M
Geriatrics; 2008 Feb; 63(2):32-7. PubMed ID: 18312021
[TBL] [Abstract][Full Text] [Related]
19. [Reversible parkinsonism induced by prolonged treatment with valproate].
Barroso B
Therapie; 2002; 57(4):410-1. PubMed ID: 12422564
[No Abstract] [Full Text] [Related]
20. Valproate-induced pseudoatrophy: expanding the clinical and imaging spectrum.
Lovett M; Skidmore DL; Mohamed IS
Pediatr Neurol; 2014 Aug; 51(2):284-5. PubMed ID: 25079580
[No Abstract] [Full Text] [Related]
[Next] [New Search]
